This public procurement record has 4 releases in its history.

Planning

22 Jul 2026 at 12:36

PlanningUpdate

15 Jul 2026 at 09:55

PlanningUpdate

23 Apr 2026 at 08:26

Planning

23 Apr 2026 at 08:14

Summary of the contracting process

NHS England is planning a national framework for lenvatinib, a pharmaceutical product used within NHS medicines procurement and supply. The framework is intended to support the supply of lenvatinib molecules across NHS organisations in England. It is being managed by NHS England’s Medicines Procurement and Supply Chain function, within NHS Medicines Value & Access. The planned arrangement is divided into regional lots covering the CESW, NWLN and LSNE areas. The procurement concerns goods rather than clinical services, manufacturing works or consultancy. It will suit pharmaceutical companies, manufacturers, marketing authorisation holders, wholesalers and other medicines suppliers able to bring the relevant lenvatinib products to market and supply NHS demand.

This procurement is at the planning stage and is not an invitation to tender. NHS England expects to use an open procedure for an above-threshold framework agreement. The stated estimated value is £35,833,000 excluding VAT, or £42,999,600 including VAT. The planned framework periods are 1 June 2027 to 31 January 2029 for CESW, 1 June 2027 to 30 September 2028 for NWLN, and 1 June 2027 to 31 May 2028 for LSNE. NHS England may extend the arrangement by up to 24 months. It expects the next notice to be published by 30 September 2026. Preliminary market engagement is scheduled, with supplier registration for a virtual meeting closing on 5 August 2026.

The preparation opportunity is most relevant to suppliers planning to launch, or already supplying, one or more lenvatinib molecules covered by the future framework. NHS England is seeking engagement with current and potential new suppliers, so companies with forthcoming product launches may be well placed to contribute. Relevant capability is likely to include pharmaceutical manufacture or authorised supply, reliable medicines distribution across NHS organisations, regulatory compliance and the capacity to support a national framework over regional contract periods. The planned market engagement will address product details, launches during the framework period, tender structure, expected timelines and key performance indicators. Businesses should therefore prepare clear information on their products, launch plans, supply capacity and service performance.

How relevant is this notice?

Notice Title

NHS National Framework for Lenvatinib

Notice Description

Project title: NHS National Framework for Lenvatinib Offer reference number: CM/TNS/26/5751 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to a maximum of 24 months. CM/TNS/26/5751 Lenvatinib Lot 1 CESW: 01/06/2027 to 31/01/2029 (20 months) Lot 2 NWLN: 01/06/2027 to 30/09/2028 (16 months) Lot 3 LSNE: 01/06/2027 to 31/05/2028 (12 months) Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England

Planning Information

NHS England is seeking to engage with current or potential new suppliers that are planning to launch any of the molecule(s) that will be covered by this procurement. Interested suppliers will be invited to a virtual preliminary market engagement meeting. The purpose of these sessions is to update suppliers regarding timelines and to discuss product details, product launches during the proposed framework period, tender structure, and KPI's. Please contact katie.noonan@nhs.net or marie.graney1@nhs.net to register your interest in tendering for this framework.

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-06891a
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/069134-2026
Current Stage
Planning
All Stages
Planning

Procurement Classification

Notice Type
UK2 - Preliminary Market Engagement Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
SME
Awardee Scale
Not specified

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products


CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£35,833,000 £10M-£100M
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
Not specified

Notice Dates

Publication Date
22 Jul 20261 months ago
Submission Deadline
Not specified
Future Notice Date
30 Sep 20262 months to go
Award Date
Not specified
Contract Period
1 Jun 2027 - 31 Jan 2029 1-2 years
Recurrence
Not specified

Notice Status

Tender Status
Planned
Lots Status
Planned
Awards Status
Not Specified
Contracts Status
Not Specified

Contracting Authority (Buyer)

Main Buyer
NHS England
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LONDON
Postcode
SE1 8UG
Postcode Area
South East London
Country
England

Major Region (ITL 1)
TLI London
Basic Region (ITL 2)
TLI4 Inner London - East
Small Region (ITL 3)
TLI45 Lambeth
Delivery Location
TLC North East (England), TLD North West (England), TLF East Midlands (England), TLG West Midlands (England), TLH East (England), TLJ South East (England), TLK South West (England)

Local Authority
Lambeth
Electoral Ward
Waterloo & South Bank
Westminster Constituency
Vauxhall and Camberwell Green

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...